Viridos Stock

viridos.comEnergyFounded: 2005Funding to Date: $35.4MM

Viridos a biotechnology company harnessing the power of algae to make renewable, low carbon and energy dense liquid fuels for heavy duty transportation applications.

Register for Details

For more details on financing and valuation for Viridos, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Viridos.

Register Today

Team

Management Team

Hamilton Smith Ph.D
Co-Founder, Board Member & Chief Scientific Officer
David Kiernan MD
Co-Founder & Board Member
Oliver Fetzer Ph.D
Board Member & Chief Executive Officer
Craig Venter Ph.D
Co-Founder & Scientific Advisor

Board Members

Alfonso Romo
Plenus
Edgardo Cantu
Kok-Thay Lim
Martine Rothblatt Ph.D
United Therapeutics
Tina Nova Ph.D
Barry Schuler
Draper Fisher Jurvetson Management
Derrik Huat
Gregory Lucier
Invitrogen
Oliver Fetzer Ph.D
Reinhard Ambros Ph.D
William McKee
Clyde Hutchison Ph.D
David Kiernan MD
Juan Enriquez
Excel Venture Management
Justin Adams
Shaun Healey
BP Ventures
Tan Thay
Genting Genomics

Other companies like Viridos in the Energy sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$4.96B
Sector
Last Round Est. Valuation
$243.33MM
Sector
Last Round Est. Valuation
$11.75B
Sector
Last Round Est. Valuation
$1.84B
Sector
Last Round Est. Valuation
$2.89B
Sector
Last Round Est. Valuation
$242.5MM

News

Synthetic Genomics, Inc. and ExxonMobil announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant progress in understanding algae genetics, growth characteristics and increasing oil production.
SAN DIEGO, Jan. 9, 2017 /PRNewswire/ -- Synthetic Genomics Inc. announced today that its subsidiary, SGI-DNA, has...
SAN DIEGO, Jan. 5, 2017 /PRNewswire/ -- Synthetic Genomics, Inc., announced today that it has entered a research and...
Updated on: Jun 5, 2023